Split History
ETFs Holding TRVN »    TRVN Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; TRV045, which is Co.'s sphingosine-1-phosphate receptor modulator that may provide a non-opioid approach to managing chronic pain; as well as TRV734, a new chemical entity targeting the same mechanism of action at the mu opioid receptor as OLINVYK. According to our TRVN split history records, Trevena has had 1 split.
TRVN split history picture
Trevena (TRVN) has 1 split in our TRVN split history database. The split for TRVN took place on November 10, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of TRVN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.

When a company such as Trevena conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the TRVN split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Trevena shares, starting with a $10,000 purchase of TRVN, presented on a split-history-adjusted basis factoring in the complete TRVN split history. TRVN split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/25/2014
End date: 04/23/2024
Start price/share: $129.00
End price/share: $0.39
Dividends collected/share: $0.00
Total return: -99.70%
Average Annual Total Return: -44.04%
Starting investment: $10,000.00
Ending investment: $30.07
Years: 10.00
Date Ratio
11/10/20221 for 25
TRVN is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TRXC Split History
TTNP Split History
TTOO Split History
TTPH Split History
TXMD Split History
UHS Split History
UNIS Split History
USPH Split History
UTHR Split History
VAR Split History

Also explore: TRVN shares outstanding history

Email EnvelopeFree TRVN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Applied DNA Sciences, Inc. (APDN)
Cidara Therapeutics, Inc. (CDTX)
Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

TRVN Insider Buying

TRVN Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.